Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran ; volume:5 ; number:1 ; day:22 ; month:4 ; year:2004 ; pages:1-7 ; date:12.2004
Trials ; 5, Heft 1 (22.4.2004), 1-7, 12.2004
- Creator
-
Boos, Christopher J.
- Contributor
-
More, Ranjit S.
SpringerLink (Online service)
- DOI
-
10.1186/1468-6708-5-3
- URN
-
urn:nbn:de:1111-2016050215442
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boos, Christopher J.
- More, Ranjit S.
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database
Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database
Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation